<?xml version='1.0' encoding='UTF-8'?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-06-27T21:32:34Z</responseDate>
  <request verb="GetRecord" identifier="oai:meral.edu.mm:recid/3029" metadataPrefix="oai_dc">https://meral.edu.mm/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:meral.edu.mm:recid/3029</identifier>
        <datestamp>2021-12-13T07:00:53Z</datestamp>
        <setSpec>1582963366982</setSpec>
        <setSpec>1582963366982:1597649184558</setSpec>
        <setSpec>user-um1</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns="http://www.w3.org/2001/XMLSchema" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Association between HLA-B* 15:02 and carbamazepine induced severe cutaneous adverse drug reactions in Myanmar</dc:title>
          <dc:creator>Amy Hui-Ping Khor</dc:creator>
          <dc:creator>Seinn Mya Mya Aye</dc:creator>
          <dc:creator>Kheng-Seang Lim</dc:creator>
          <dc:creator>Yan Lynn Aung</dc:creator>
          <dc:creator>Yin Minn Aye</dc:creator>
          <dc:creator>Ohnmar</dc:creator>
          <dc:creator>Win Min Thit</dc:creator>
          <dc:creator>Chong-Tin Tan</dc:creator>
          <dc:creator>Ching-Ching Ng</dc:creator>
          <dc:description>Genetic predisposition to carbamazepine (CBZ)-induced Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) had been reported in several Southeast Asian populations, but not in Myanmar. Previous studies had so far reported more than 70% of CBZ-induced SJS/TEN cases
positive for HLA-B*15:02 allele.1-4 Myanmar, as the second largest country in Southeast Asia with a population of 54.5 million, has high HLA-B*15:02 carrier frequency in its general population (27.3- 49.1%).5,6.</dc:description>
          <dc:date>2017-12-15</dc:date>
          <dc:identifier>http://hdl.handle.net/20.500.12678/0000003029</dc:identifier>
          <dc:identifier>https://meral.edu.mm/records/3029</dc:identifier>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
